Inflammation

Latest News

Periostin Bests Eosinophil Count for Biomarker Predictability in ECRS
Periostin Bests Eosinophil Count for Biomarker Predictability in ECRS

February 2nd 2023

Known to be a contributing factor to polyp development at high levels, periostin’s potential as a biomarker for eosinophilic chronic rhinosinusitis (ECRS) severity was investigated in a new study in which outcomes were compared between patients who had ECRS and those with non-ECRS.

Biomarkers Indicate Potential Need for Chronic Rhinosinusitis Surgery
Biomarkers Indicate Potential Need for Chronic Rhinosinusitis Surgery

January 25th 2023

Early Diagnosis Vital to Prevent Impairment From Pediatric EGIDs
Early Diagnosis Vital to Prevent Impairment From Pediatric EGIDs

January 20th 2023

Adherence to Postop Treatment May Indicate Early Recurrence of CRSwNP
Adherence to Postop Treatment May Indicate Early Recurrence of CRSwNP

January 17th 2023

Inflammation Biomarker Potential Investigated in New CRSwNP Study
Inflammation Biomarker Potential Investigated in New CRSwNP Study

January 11th 2023

Video Interviews

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.